Clinical Trial Update: Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated ALV003 in healthy adult volunteers and individuals with well-controlled celiac disease after a gluten-containing meal; the trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• ALV003

Snippet

Sponsor: Alvine Pharmaceuticals Inc. | Conditions: Celiac Disease | Phase 1 | Status: COMPLETED